A protein interaction network centered on leucine-rich repeats and immunoglobulin-like domains 1 (LRIG1) regulates growth factor receptors
Open Access
- 1 March 2018
- journal article
- research article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 293 (9) , 3421-3435
Abstract
No abstract availableKeywords
This publication has 62 references indexed in Scilit:
- The soluble form of the tumor suppressor Lrig1 potently inhibits in vivo glioma growth irrespective of EGF receptor statusNeuro-Oncology, 2013
- Lrig1 controls intestinal stem-cell homeostasis by negative regulation of ErbB signallingNature Cell Biology, 2012
- The Pan-ErbB Negative Regulator Lrig1 Is an Intestinal Stem Cell Marker that Functions as a Tumor SuppressorCell, 2012
- Canopy1, a positive feedback regulator of FGF signaling, controls progenitor cell clustering during Kupffer's vesicle organogenesisProceedings of the National Academy of Sciences, 2011
- Paraoxonase 2 Deficiency Alters Mitochondrial Function and Exacerbates the Development of AtherosclerosisAntioxidants & Redox Signaling, 2011
- Folding of Toll-like receptors by the HSP90 paralogue gp96 requires a substrate-specific cochaperoneNature Communications, 2010
- edgeR: a Bioconductor package for differential expression analysis of digital gene expression dataBioinformatics, 2009
- An Unbiased Screen Identifies DEP-1 Tumor Suppressor as a Phosphatase Controlling EGFR EndocytosisCurrent Biology, 2009
- Lrig1 Expression Defines a Distinct Multipotent Stem Cell Population in Mammalian EpidermisCell Stem Cell, 2009
- IDH1andIDH2Mutations in GliomasNew England Journal of Medicine, 2009